Exosome-mediated transport of MIF has been shown to suppress temozolomide resistance in gliomas by modulating the TIMP3/phosphatidylinositol 3-kinase (PI3K)/AKT signaling axis [44]. This evidence concerns the gene AKT1 and central nervous system cancer.